arrow
Back
I

Instituto De CiêNcia E Tecnologia

Scholars12
Papers6
Citations0
Related Papers (6)
Publication Date
Data augmentation in multimodal frameworks: a survey
err2026-08-14
err0
errOAAI
errDavi Fileti; Márcio Basgalupp; João Gama; André Carvalho
errShare
errSave
Process Optimization and Validation of Functional Pasta Reformulated with Lupin and Flaxseed Flours: Impacts on Technological Quality, Bioactive Potential, and Sensory Attributes
err2026-08-10
err0
errOAAI
errLuz María Paucar-Menacho; Alicia Lavado-Cruz; Rebeca Salvador-Reyes; Anggie Verona-Ruiz; John Gonzales-Capcha; Soledad Quezada-Berrú; Cesar Moreno-Rojo; Sander Moreira Rodrigues; Marcio Schmiele
errShare
errSave
Constant reference tracking control for uncertain linear sampled-data systems
err2025-10-11
err0
PREAI
errRoberto M. Fuentes; Gabriela W. Gabriel; André M. de Oliveira; Jonathan M. Palma
errShare
errSave
Corrigendum to “Cost-effective production process of scFv antibody fragments against Shiga toxin 2 via recombinant E. coli” [Curr. Res. Biotechnol. 10 (2025) 100310]
err2025-07-17
err0
PREAI
errMarcela Guimarães; Daniela Luz; Elisabeth de Fátima Pires Augusto; Lucia Vieira; Maricilia Silva Costa; Roxane Maria Fontes Piazza; José Geraldo da Cruz Pradella
errShare
errSave
Peptides derived from the POU domain of BRN2 show antitumor activity against murine melanoma model cells in vitro and in vivo
err2025-07-02
err0
PREAI
errMaria Carolina Mariano Cesar; Agnes Kobayashi Calvo de Sant’ana; Renato Arruda Mortara; Victória Santos Souza; Thaysa Paschoalin; Marco Antônio Soufen; Juliana Machado Anastácio; Erenildo F. Macedo; Fernanda Fernandes Miranda da Cunha; Dayane Batista Tada; Denise Costa Arruda
errShare
errSave
Cost-effective production process of scFv antibody fragments against Shiga toxin 2 via recombinant E. coli
err2025-06-30
err0
errOAAI
errMarcela Guimarães; Daniela Luz; Elisabeth de Fátima Pires Augusto; Lucia Vieira; Maricilia Silva Costa; Roxane Maria Fontes Piazza; José Geraldo da Cruz Pradella
errShare
errSave